Highlights of Winter Clinical Hawaii 2024
Derms and Conditions
by Dermsquared
1M ago
In this episode of Derms and Conditions, our host, James Q. Del Rosso, DO, is joined by April Armstrong, MD, MPH, and David Cohen, MD, MPH, live at Winter Clinical Hawaii 2024 to review highlights from the conference.  They cover a diverse slate of topics, including the 2023 allergen of the year (lanolin), notable advancements in psoriasis treatment including topicals and biologics, updates on diagnostic tools for melanoma, and clinical pearls for treating actinic keratosis with combinations of cryosurgery, topical field therapy, and PDT. The group reviews guidelines for atopic derma ..read more
Visit website
A Deep Dive Into IL-17 Inhibition and Bimekizumab for Psoriasis: Straight Talk with Dr Andy Blauvelt
Derms and Conditions
by Dermsquared
2M ago
In this episode of Derms and Conditions, Andy Blauvelt, MD, joins James Q. Del Rosso, DO, to discuss IL-17 inhibition, with a focus on bimekizumab as a treatment for psoriasis. Bimekizumab is unique for inhibiting both IL-17A and IL-17F, demonstrating higher efficacy and a favorable safety profile. Dr Blauvelt highlights the drug's mechanism of action and covers its approval process, global use, and notable data. He emphasizes its efficacy in achieving Psoriasis Area Severity Index 100 (PASI 100) clearance. The pair discusses bimekizumab’s dosing schedule, with an induction dosing period of on ..read more
Visit website
Final Thoughts from 2023: Highlights from Podcasts Past…
Derms and Conditions
by Dermsquared
2M ago
In this episode of Derms and Conditions, our host, Dr James Q. Del Rosso, reflects on the past year of podcasting, offering a rich summary of key dermatologic topics discussed throughout 2023.  To start, the episode delves into highlights from an interview with Dr Shane Chapman, who specializes in skin cancer. Dr Chapman shares insights into nonsurgical options for treating nonmelanoma skin cancer, focusing on strategies for cases of squamous cell carcinoma and nodular basal cell carcinoma that may not be amenable to surgical treatment for a variety of reasons. Next, Dr Del Rosso features ..read more
Visit website
Untangling the Questions and Challenges in Patients with Hair Loss: Part 2
Derms and Conditions
by Dermsquared
2M ago
In episode 67 of Derms and Conditions, our host, Dr James Q. Del Rosso, sits down again with Dr Jeff Donovan, a board-certified dermatologist who practices in Whistler, Canada, with his dermatology clinic dedicated solely to the management of hair disorders, for part two of their discussion on alopecia areata and other hair loss conditions. Dr Donovan begins the discussion by addressing autoimmune thyroid disease associated with alopecia areata and the appropriate laboratory interpretation and monitoring for these patients. He discusses the comprehensive baseline laboratory tests he collects b ..read more
Visit website
Untangling the Questions and Challenges in Patients with Hair Loss: Part 1
Derms and Conditions
by Dermsquared
2M ago
In episode 66 of Derms and Conditions, our host, Dr James Q. Del Rosso, sits down with Dr Jeff Donovan, a board-certified dermatologist who practices in Whistler, Canada, with his dermatology clinic dedicated only to management of hair disorders. In part one of this series, they discuss how to approach patients with alopecia areata. Dr Donovan starts by discussing conditions that can mimic alopecia areata and when a biopsy may be needed to confirm the diagnosis, prompting him to share his suggestions on biopsy caliber, appropriate sites for biopsy, and utilizing the right pathologist to review ..read more
Visit website
Does Bimekizumab Raise the Bar of Success for Moderate-to-Severe Plaque Psoriasis? Perspectives from Dr. Ted Rosen
Derms and Conditions
by Dermsquared
2M ago
In episode 65 of Derms and Conditions, our host, James Q Del Rosso, DO, chats with Ted Rosen, MD, Professor of Dermatology at Baylor College of Medicine and Chief of Dermatology Service at Michael E. DeBakey Veterans Affairs Medical Center, to discuss new developments in psoriasis treatment. They begin by discussing the current psoriasis treatment landscape and the perception that with effective biologics now on the market, there are no longer any unmet needs in psoriasis treatment. They reflect on the importance of having a variety of treatment options with differing mechanisms of action, whi ..read more
Visit website
Beyond the Knife: Practical Nonsurgical Options for Skin Cancer
Derms and Conditions
by Dermsquared
3M ago
In Episode 64 of Derms and Conditions, our host, Dr James Q. Del Rosso sits down with Dr Shane Chapman, Chair of the Department of Dermatology at Dartmouth Hitchcock Medical Center, to discuss nonsurgical approaches to treating nonmelanoma skin cancer.  Dr. Chapman begins by discussing topical treatment options for nonmelanoma skin cancer for patients who are not candidates for surgery. He comments on the use of intralesional chemotherapy for keratoacanthomas or squamous cell carcinomas in poorly healing areas or when multiple lesions are present, compares the benefits of 5-fluorouracil a ..read more
Visit website
What is Dr Adam Friedman Up To Now?
Derms and Conditions
by Dermsquared
4M ago
In Episode 63 of Derms and Conditions, our host, James Q. Del Rosso, DO, sits down with Adam Friedman, MD, to discuss some important topics in dermatology, including a comprehensive resource for portraying skin conditions and his research findings relating to sensitive skin. Dr Friedman begins by describing his atlas project, created to address a gap in dermatology in the limited way textbooks and atlases portray skin conditions. The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas is a comprehensive resource that depicts dermatologic conditions across the full spectr ..read more
Visit website
Live From Las Vegas! Greatest Hits from Fall Clinical Dermatology 2023
Derms and Conditions
by Dermsquared
4M ago
In this episode of Derms and Conditions, Dr. Jim Del Rosso and Dr. Gary Goldenberg discuss some of the highlights from the meeting. These include recent FDA approvals such as bimekizumab for psoriasis and the triple topical combination for acne vulgaris, the newer  nonsteroidal topical agents, tapinarof and roflumilast, and their relevant clinical use, the  significance of narrow-spectrum oral antibiotic therapy with sarecycline as compared to  other oral tetracycline with regard to antibiotic resistance, and physical devices such as laser systems used to treat acne vulgaris.&nb ..read more
Visit website
Once Is Not Enough: Round 2 on Therapeutic Insights
Derms and Conditions
by Dermsquared
5M ago
In episode 61 of Derms and Conditions, our host, James Q. Del Rosso, DO, presents a self-made episode where he clarifies key points on many therapies relevant to every-day clinical practice. First, he discusses topical alpha-agonist therapy for persistent facial erythema (PFE) of rosacea. Long-term data shows that daily use of either topical oxymetazoline or brimonidine appears to “reset” (lower) the baseline level of PFE in patients with rosacea.  Next, he talks about sub-antibiotic dosing of doxycycline and how its anti-inflammatory properties, including support of the dermal matrix, c ..read more
Visit website

Follow Derms and Conditions on FeedSpot

Continue with Google
Continue with Apple
OR